Please login to the form below

Not currently logged in
Email:
Password:

Senior changes at EMA

New head of IT and chair of committee for advanced therapies
EMA Dina Tsiambaou

The European Medicines Agency (EMA) has announced changes in leadership for both its IT division and its Committee for Advanced Therapies (CAT).

Dina Tsiambaou (pictured) joins the Agency, which regulates medicines in the EU, as head of the IT development department. She was previously a senior manager in IT at management consultancy Accenture.

In this role she gained experience working in a number of regions, including China, Mauritius, Thailand, Singapore, Turkey, the US, Germany and Ireland.

The EMA's other new appointment was that of Dr Paula Salmikangas as chair of the CAT, the EMA committee responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products.

She was previously vice-chair of the committee and succeeds Christian Schneider, who had chaired the CAT since its creation in 2009.

In addition to her EMA role, Dr Salmikangas is a senior research at the Finnish Medicines Agency.

18th February 2014

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics